Invaio Sciences, Inc.,
a company focused on unlocking the potential of the planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges, announced today an agreement with the world-renowned Fundecitrus, Fund for Citrus Protection, located in Araraquara, Brazil. The agreement focuses on the collaboration to evaluate the use of a novel natural peptide to control the devastating disease Citrus Greening (HLB) in Brazilian citrus trees.
The agreement will leverage Fundecitrus' deep expertise in Citrus grove and pest management to evaluate application details of the novel peptide maSAMP in locally relevant conditions. The peptide, developed by Dr. Hailing Jin of the University of California Riverside, and licensed for global commercialization by Invaio, has previously been proven under greenhouse conditions to reduce the multiplication of pathogen that causes HLB/Citrus Greening – a severe plant disease carried by an insect called the Asian citrus psyllid that has dramatically and rapidly threatened the citrus industry by devastating millions of acres of citrus crops throughout the world.
Fundecitrus is a non-profit private Brazilian Citrus Industry Association that works for the interests of the citrus growers and industry. Founded 44 years ago in the state of São Paulo, the organization promotes the sustainable development of citrus production in Brazil. Through its cutting-edge research facilities, hundreds of hectares of field trials in commercial orchards, and more than 130 staff and research members, Fundecitrus has been leading efforts to ensure that Brazilian citrus growers have access to the latest technologies, techniques, and information enabling the sustainable production of citrus products.
"Brazil is currently the largest producer of oranges in the world, with 17 million tons of the fruit produced annually (21% of global production) and supplying over 50% of global juice production," explains Peleg Chevion, President & Chief Commercial Officer at Invaio Sciences.
Chevion continues, "The collaboration will focus on the application of Invaio's pioneering technologies to evaluate efficacy and assess measurable improvements to tree health. We are already testing the technology in field trials in Florida and the goal of the Fundecitrus collaboration is to bring the benefit of this game changing technology to Brazil, as well as to other Citrus growing regions, which have already suffered, or are expected to suffer immense losses from the devastating effects of the HLB disease."
"We are very pleased to work with some of the world's leading experts in HLB management in Brazil, to best understand how to apply this sustainable and innovative technology and improve the economic conditions of citrus growers", commented Avram Slovic, Sr. Commercial Director of Latin America. "While we understand these studies are preliminary, we are confident that together with Fundecitrus we have the right team in place in order to integrate our technologies with current practices."
For more information: invaio.com